"10.1371_journal.pone.0063012","plos one","2013-05-08T00:00:00Z","Per Björk; Eva Källberg; Ulf Wellmar; Matteo Riva; Anders Olsson; Zhifei He; Marie Törngren; David Liberg; Fredrik Ivars; Tomas Leanderson","Immunology Group, Lund University, Lund, Sweden; Active Biotech AB, Lund, Sweden","Conceived and designed the experiments: TL FI DL. Performed the experiments: UW PB EK AO ZH MT MR. Analyzed the data: PB EK AO MT DL FI TL. Wrote the paper: DL FI TL.","UW, DL, AO, PB and MT are full time employees of Active Biotech AB that develops S100A9 binding molecules for commercial development. TL is a part time employee of Active Biotech AB. FI receives a research grant from Active Biotech AB. There are no further patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","05","Per Björk","PB",10,TRUE,3,7,7,3,TRUE,TRUE,FALSE,0,NA,FALSE
